Javascript must be enabled to continue!
The Pransky interview: Dr Paolo Pirjanian, CTO of iRobot Corporation
View through CrossRef
Purpose
– PhD/inventor builds consumer robot start-up company based on low-cost, groundbreaking visual simultaneous localization and mapping (vSLAM) visual sensors and NorthStar® navigation technologies that sells for nearly $75 million dollars 12 years later. The following article is a “Q&A interview” conducted by Joanne Pransky of Industrial Robot Journal as a method to impart the combined technological, business, and personal experience of a prominent, robotic industry engineer-turned entrepreneur regarding the evolution, commercialization, and challenges of bringing a technological invention to market. The paper aims to discuss these issues.
Design/methodology/approach
– This interview was with Dr Paolo Pirjanian, CTO of iRobot Corporation. Dr Pirjanian previously served as both CTO and CEO of Evolution Robotics. Dr Pirjanian received his PhD degree from Aalborg University, Denmark. He has received several honors and awards including the IEEE Robotics and Automation Society Early Career Award in 2004 and the Technical Leadership Award from JPL/NASA. Dr Pirjanian holds 67 patents.
Findings
– The challenges and solutions of transferring technological innovations into an affordable consumer product are presented. The resulting pioneering technologies and approximate 37 patents around vSLAM and NorthStar® were incorporated into Evolution's flagship consumer product, Mint floor cleaning robot. In October 2012, iRobot Corp acquired Evolution for $74 million in an effort to complement their own products and technologies.
Originality/value
– A robot scientist, in his roles as the CTO and CEO of a robot company, uses a paradigm shift in vision and pattern recognition to build an affordable consumer product and successful company.
Title: The Pransky interview: Dr Paolo Pirjanian, CTO of iRobot Corporation
Description:
Purpose
– PhD/inventor builds consumer robot start-up company based on low-cost, groundbreaking visual simultaneous localization and mapping (vSLAM) visual sensors and NorthStar® navigation technologies that sells for nearly $75 million dollars 12 years later.
The following article is a “Q&A interview” conducted by Joanne Pransky of Industrial Robot Journal as a method to impart the combined technological, business, and personal experience of a prominent, robotic industry engineer-turned entrepreneur regarding the evolution, commercialization, and challenges of bringing a technological invention to market.
The paper aims to discuss these issues.
Design/methodology/approach
– This interview was with Dr Paolo Pirjanian, CTO of iRobot Corporation.
Dr Pirjanian previously served as both CTO and CEO of Evolution Robotics.
Dr Pirjanian received his PhD degree from Aalborg University, Denmark.
He has received several honors and awards including the IEEE Robotics and Automation Society Early Career Award in 2004 and the Technical Leadership Award from JPL/NASA.
Dr Pirjanian holds 67 patents.
Findings
– The challenges and solutions of transferring technological innovations into an affordable consumer product are presented.
The resulting pioneering technologies and approximate 37 patents around vSLAM and NorthStar® were incorporated into Evolution's flagship consumer product, Mint floor cleaning robot.
In October 2012, iRobot Corp acquired Evolution for $74 million in an effort to complement their own products and technologies.
Originality/value
– A robot scientist, in his roles as the CTO and CEO of a robot company, uses a paradigm shift in vision and pattern recognition to build an affordable consumer product and successful company.
Related Results
Abstract 16621: Factors Influencing the Difficulty of Guidewire Passage in Duplex-Guided Endovascular Treatment for Femoropopliteal Chronic Total Occlusions
Abstract 16621: Factors Influencing the Difficulty of Guidewire Passage in Duplex-Guided Endovascular Treatment for Femoropopliteal Chronic Total Occlusions
Introduction:
Previous studies have shown the effectiveness of duplex-guided endovascular treatment (EVT) for femoropopliteal chronic total occlusions (FP-CTO). However...
The Pransky interview: Dr Rodney Brooks, Robotics Entrepreneur, Founder and CTO of Rethink Robotics
The Pransky interview: Dr Rodney Brooks, Robotics Entrepreneur, Founder and CTO of Rethink Robotics
Purpose
– This article, a “Q&A interview” conducted by Joanne Pransky of Industrial Robot Journal, aims to impart the combined technological, business, and pers...
Development and first results of a dedicated chronic total occlusion programme
Development and first results of a dedicated chronic total occlusion programme
Abstract
Objective
To describe the development and first results of a dedicated chronic total occlusion (CTO) programme in a tertiary medical centre...
Complete vs. incomplete percutaneous revascularization in patients with chronic total coronary artery occlusion
Complete vs. incomplete percutaneous revascularization in patients with chronic total coronary artery occlusion
IntroductionThere is current controversy surrounding the benefits of percutaneous coronary intervention (PCI) of chronic total coronary occlusions (CTO). We aimed to evaluate the i...
The intracoronary wires hand-in-hand technique for uncrossable bilateral microcatheters in CTO lesions: a single-center case series
The intracoronary wires hand-in-hand technique for uncrossable bilateral microcatheters in CTO lesions: a single-center case series
BackgroundThe tip-in and rendezvous techniques are alternative strategies for antegrade conversion when the retrograde microcatheter (MC) cannot cross the chronic total occlusion (...
Abstract 14285: Comparison of Percutaneous Coronary Intervention-Related Adverse Cardiac Outcomes in Patients With In-Stent versus De Novo Chronic Total Occlusion: A Systematic Review and Meta-Analysis
Abstract 14285: Comparison of Percutaneous Coronary Intervention-Related Adverse Cardiac Outcomes in Patients With In-Stent versus De Novo Chronic Total Occlusion: A Systematic Review and Meta-Analysis
Introduction:
Contemporary literature reveals a range of cardiac complications in patients who receive the percutaneous coronary intervention (PCI) for chronic total oc...
The Pransky interview: Mitchell Weiss, CTO, Seegrid Corporation
The Pransky interview: Mitchell Weiss, CTO, Seegrid Corporation
Purpose
The purpose of this paper is a “Q&A interview” conducted by Joanne Pransky of Industrial Robot Journal as a method to impart the combined technological, business and pe...
Case Report: An innovative approach to coronary artery perforation in chronic total occlusion using autologous flaps
Case Report: An innovative approach to coronary artery perforation in chronic total occlusion using autologous flaps
BackgroundA percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) carries a significant risk of coronary artery perforation (CAP). The typical treatment for pr...

